Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients

Volume: 71, Issue: 6, Pages: 636 - 650
Published: Feb 1, 2018
Abstract
Small studies have reported superiority of sirolimus (SRL) over calcineurin inhibitor (CNI) in mitigating cardiac allograft vasculopathy (CAV) after heart transplantation (HT). However, data on the long-term effect on CAV progression and clinical outcomes are lacking. The aim of this study was to test the long-term safety and efficacy of conversion from CNI to SRL as maintenance therapy on CAV progression and outcomes after HT. A cohort of 402...
Paper Details
Title
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients
Published Date
Feb 1, 2018
Volume
71
Issue
6
Pages
636 - 650
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.